Transparency

We believe in providing an open environment to help build a foundation of trust and respect among our colleagues, healthcare professionals, patients, stockholders, and the public. Making information available is important as we continue to operate our business to the highest standards, and in keeping with current laws and regulations.

We are firmly focused on Our Mission and take our responsibility for transparency seriously. Sustainability reporting is a clear example of an area in which we will continue to work to increase transparency as we show progress towards our Sustainability 2020 Goals (on our U.S. Corporate Site).
 

Australia - Interactions with Healthcare Professionals

Bristol-Myers Squibb is widely recognised for excellence in providing some of the world's most important medicines for patients. At the same time, we strive to be transparent by providing information about treatments we are studying, whether they are investigational compounds, or new indications for existing marketed products.

At Bristol-Myers Squibb we work in partnership with many organisations and individuals to meet the needs of patients. Bristol-Myers Squibb is committed to working in partnership with others in a way which is fully compliant with the Medicines Australia's Code of Conduct. Our objective is to act ethically and transparently with our stakeholders and the wider community. Information on the transparency requirements under the Medicines Australia Code of Conduct can be found in the links below or on the Medicines Australia Website.

Please use the links below for further information:

Collection Statement – Healthcare Professional Engagement

Triangle Icon

Disclosure Reports

Triangle Icon

Frequently Asked Questions

Triangle Icon

Australia Code of Conduct

Triangle Icon

If you have a question about transactions reported by Bristol-Myers Squibb, email your inquiries to:

mg-transparency_bms@bms.com